Vitanova Biomedical, Inc.

Vitanova Biomedical, Inc.

VNB has developed a novel technique to use photo activation of a caged H+ carrier, o-nitrobenzaldehyde (NBA), to produce significant reductions in pHi causing rapid apoptosis (programmed cell death) within the cancer tumor.

Area of focus: 
Oncology
Commencement date: 
08/01/2017

Share